Table 1.
Clinical demographics of the prostate cancer cohort (n = 96)
| Age (y) | |
| Maximum | 75 |
| Minimum | 42 |
| Median | 62 |
| PSA (ng/mL) | |
| Maximum | 24.23 |
| Minimum | 1.9 |
| Median | 5.1 |
| PSA <10 | 83 |
| PSA 10-<20 | 10 |
| PSA≥20 | 3 |
| Gleason score | |
| <7 | 12 |
| 7 | 71 |
| >7 | 13 |
| Tumor stage | |
| pT2 | 62 |
| pT3 | 32 |
| pT4 | 2 |
| Surgical margin | |
| Negative | 80 |
| Positive | 16 |
| PSA biochemical recurrencea | |
| No | 86 |
| Yes | 9 |
Clinical follow-up of 1 patient was not available.